Table 3. Cardiovascular disease risk classification comparing the Framingham risk score at baseline with the Framingham risk score at the second health examination in the EPIC-Norfolk cohort (n = 12,197).
Individuals who developed cardiovascular events | ||||
Framingham risk score at the 2nd health examination | ||||
< 10.0% | 10.0–19.9% | ≥ 20.0% | ||
Framingham risk score at baseline | Total | |||
< 10.0% | 95 | 57 | 2 | 154 |
10.0–19.9% | 30 | 230 | 145 | 405 |
≥ 20.0% | 3 | 68 | 741 | 812 |
Total | 128 | 355 | 888 | 1,371 |
Individuals who did not develop cardiovascular events | ||||
Framingham risk score at the 2nd health examination | ||||
< 10.0% | 10.0–19.9% | ≥ 20.0% | ||
Framingham risk score at baseline | Total | |||
< 10.0% | 3,994 | 1,060 | 41 | 5,095 |
10.0–19.9% | 330 | 2,034 | 886 | 3,250 |
≥ 20.0% | 13 | 312 | 2,156 | 2,481 |
Total | 4,337 | 3,406 | 3,083 | 10,826 |
Note: The net reclassification improvement was 4.8%, p = 0.99